4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-20-022057
CEO and CFO bought 2,000 shares at $5.40 ($10,795)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2020-11-19 | Purchase | +2,000 | $5.40 | $10,795 | 1,186,839 | D: show line 1 in the form |
| Open-market purchases · 2,000 sh · avg $5.40 · $10,795 | |||||||
Loading xslF345X03/ownership.xml…